BlackRock’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.4M Buy
3,326,560
+118,771
+4% +$1.31M ﹤0.01% 2993
2026
Q1
$36.8M Buy
3,207,789
+67,951
+2% +$897K ﹤0.01% 2711
2025
Q4
$47.6M Buy
3,139,838
+2,268
+0.1% +$34.6K ﹤0.01% 2547
2025
Q3
$45.9M Sell
3,137,570
-73,981
-2% -$971K ﹤0.01% 2563
2025
Q2
$35.8M Buy
3,211,551
+149,354
+5% +$1.85M ﹤0.01% 2653
2025
Q1
$49.9M Sell
3,062,197
-13,194
-0.4% -$232K ﹤0.01% 2375
2024
Q4
$53.7M Sell
3,075,391
-54,627
-2% -$950K ﹤0.01% 2411
2024
Q3
$48.9M Sell
3,130,018
-56,792
-2% -$910K ﹤0.01% 2484
2024
Q2
$42.3M Sell
3,186,810
-106,420
-3% -$1.46M ﹤0.01% 2517
2024
Q1
$47.8M Sell
3,293,230
-24,089
-0.7% -$333K ﹤0.01% 2458
2023
Q4
$44.7M Sell
3,317,319
-2,646,049
-44% -$31.1M ﹤0.01% 2541
2023
Q3
$76.7M Buy
5,963,368
+5,649
+0.1% +$102K ﹤0.01% 2144
2023
Q2
$108M Sell
5,957,719
-49,141
-0.8% -$918K ﹤0.01% 2001
2023
Q1
$101M Buy
6,006,860
+2,144,154
+56% +$42M ﹤0.01% 2014
2022
Q4
$79.3M Buy
3,862,706
+134,285
+4% +$2.37M ﹤0.01% 2164
2022
Q3
$71.2M Buy
3,728,421
+185,310
+5% +$4.17M ﹤0.01% 2184
2022
Q2
$83.4M Buy
3,543,111
+119,023
+3% +$3.41M ﹤0.01% 2141
2022
Q1
$112M Buy
3,424,088
+30,329
+0.9% +$974K ﹤0.01% 2072
2021
Q4
$106M Buy
3,393,759
+155,154
+5% +$5.19M ﹤0.01% 2184
2021
Q3
$123M Sell
3,238,605
-75,332
-2% -$3M ﹤0.01% 2082
2021
Q2
$133M Buy
3,313,937
+52,792
+2% +$2.23M ﹤0.01% 2078
2021
Q1
$141M Buy
3,261,145
+172,290
+6% +$7.6M ﹤0.01% 1975
2020
Q4
$133M Buy
3,088,855
+96,116
+3% +$3.51M ﹤0.01% 1899
2020
Q3
$93.2M Sell
2,992,739
-27,702
-0.9% -$859K ﹤0.01% 1931
2020
Q2
$96.7M Buy
3,020,441
+117,755
+4% +$3.91M ﹤0.01% 1860
2020
Q1
$81.3M Sell
2,902,686
-96,276
-3% -$3.72M ﹤0.01% 1774
2019
Q4
$138M Buy
2,998,962
+100,467
+3% +$4.72M 0.01% 1756
2019
Q3
$154M Buy
2,898,495
+52,448
+2% +$2.71M 0.01% 1615
2019
Q2
$150M Sell
2,846,047
-22,557
-0.8% -$1.2M 0.01% 1630
2019
Q1
$162M Sell
2,868,604
-39,993
-1% -$2.24M 0.01% 1562
2018
Q4
$153M Buy
2,908,597
+60,189
+2% +$3.42M 0.01% 1516
2018
Q3
$165M Buy
2,848,408
+82,303
+3% +$4.61M 0.01% 1619
2018
Q2
$157M Buy
2,766,105
+112,878
+4% +$6.43M 0.01% 1630
2018
Q1
$156M Buy
2,653,227
+189,215
+8% +$10.6M 0.01% 1542
2017
Q4
$135M Buy
2,464,012
+192,830
+8% +$10M 0.01% 1661
2017
Q3
$107M Buy
2,271,182
+65,659
+3% +$3.09M 0.01% 1819
2017
Q2
$103M Sell
2,205,523
-11,335
-0.5% -$470K 0.01% 1780
2017
Q1
$84.6M Buy
2,216,858
+2,215,282
+140,564% +$82M ﹤0.01% 1889
2016
Q4
$57K Sell
1,576
-5,663
-78% -$215K ﹤0.01% 2867
2016
Q3
$309K Buy
7,239
+4,100
+131% +$183K ﹤0.01% 1932
2016
Q2
$133K Buy
3,139
+1,672
+114% +$72.7K ﹤0.01% 2353
2016
Q1
$61K Buy
1,467
+414
+39% +$16.2K ﹤0.01% 2257
2015
Q4
$41K Buy
1,053
+443
+73% +$16.5K ﹤0.01% 2174
2015
Q3
$20K Hold
610
﹤0.01% 2390
2015
Q2
$20K Hold
610
﹤0.01% 2405
2015
Q1
$22K Hold
610
﹤0.01% 2322
2014
Q4
$19K Hold
610
﹤0.01% 2397
2014
Q3
$19K Hold
610
﹤0.01% 2361
2014
Q2
$22K Sell
610
-69
-10% -$2.23K ﹤0.01% 2332
2014
Q1
$21K Hold
679
﹤0.01% 2342
2013
Q4
$15K Hold
679
﹤0.01% 2499
2013
Q3
$14K Hold
679
﹤0.01% 2447
2013
Q2
$18K Buy
+679
New +$20.3K ﹤0.01% 2352

Other funds holding OFIX

BlackRock's OFIX Position: Q2 2026 in Review

BlackRock increased its Orthofix Medical (OFIX) stake by 3.7% in Q2 2026, buying an estimated $1.31M and bringing the position to 3,326,560 shares worth $30.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2993.

BlackRock first reported a position in OFIX in Q2 2013 and has held it in 53 quarters since. The position peaked at $165M in Q3 2018. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • BlackRock held 3,326,560 shares of Orthofix Medical worth $30.4M as of Q2 2026.
  • BlackRock bought 118,771 Orthofix Medical shares in Q2 2026, an estimated $1.31M.
  • Orthofix Medical made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2993 holding.
  • BlackRock first reported a position in Orthofix Medical in Q2 2013 and has held it in 53 quarters since.
  • BlackRock's Orthofix Medical position peaked at $165M in Q3 2018.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.